Riskpilot← Back to searchSign inGet full accessSAM Nordic Oy
OYActiveY-tunnus 2630593-7Datagränden 4Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20143 employeeswww.samnordic.fi
Revenue 2025
EUR 1,4M
+16% vs 2024
EBITDA margin
7.7%
+1316% vs 2024
Equity ratio
56.1%
Financial strength
Net profit 2025
EUR 84K
+1293% vs 2024
| Revenue | EUR 1,4M | +16% |
| EBITDA | EUR 105K | +1316% |
| Net profit | EUR 84K | +1293% |
| Total assets | EUR 533K | -95% |
| Equity | EUR 299K | +39% |
| Employees | 3 | — |
Legal name
SAM Nordic Oy
Y-tunnus number
2630593-7
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
7. heinäkuuta 2014
Share capital
EUR 2 500
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Bolagets verksamhetsområde är: bolaget skall bedriva import och export samt försäljning av sjukvårdsutmstning samt därmed förenlig verksamhet.
Address
Datagränden 4
Phone
+358961593300
Email
info@samnordic.fi
Website
www.samnordic.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 173 | 1 068 | 0 | 1 185 | 1 373 |
| Staff expenses | −324 | −240 | −0 | −333 | −241 |
| EBITDA | 60 | 141 | 0 | 7 | 105 |
| Depreciation & amort. | — | — | −0 | −0 | −0 |
| EBIT | 60 | 141 | 0 | 7 | 105 |
| Net financials | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 60 | 141 | 0 | 7 | 105 |
| Tax | 11 | 28 | −0 | −0 | 21 |
| Net profit | 49 | 113 | 0 | 6 | 84 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 459 | 345 | 215 | 10 701 | 533 |
| Equity | 92 | 205 | 209 | 215 | 299 |
| Long-term debt | 57 | — | 0 | 0 | 0 |
| Short-term debt | 309 | 140 | 150 | 84 | 102 |
| Total debt | 366 | 140 | 150 | 84 | 102 |
EBITDA margin
7.7%
This company
15.8%
Market median
-51% vs market
20212025
Equity ratio
56.1%
This company
38.2%
Market median
+47% vs market
20212025
Return on equity
28.2%
This company
18.4%
Market median
+53% vs market
20212025
Net profit margin
6.1%
This company
8.1%
Market median
-25% vs market
20212025
Asset turnover
2.57×
This company
1.12×
Market median
+129% vs market
20212025
Debt / equity
0.78×
This company
0.62×
Market median
+26% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
DL Deputy Member | Deputy Member | 2014 |
PJ Person with significant control | Person with significant control | 2025 |
| Former (2) | ||
PB Audit | Audit | 2020 – 2023 |
TS Person with significant control | Person with significant control | 2020 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2014 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SAM Nordic Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Birger Åhman | Audit | 0 companies |
| Tuomas Seppo Antero Suikki | Person with significant control | 0 companies |
| David Lundquist | Deputy Member | 0 companies |
| Petra Johanna Vuorinen | Person with significant control | 0 companies |
| Heidi Maria Isabell Ahlén | Board of Directors | 0 companies |